The Organoid Company
The Organoid Company provides accessible digital biology tools and ready-to-use organoid models to speed drug discovery. Our platform combines AI-assisted design for small molecules and proteins with seamless in silico to in vitro workflows. Key technologies include end-to-end automation, physiologically relevant organoid libraries, and integrated quality control. Researchers can run disease-model experiments from the library or request bespoke organoid development, with scalable production. The company targets B2B research and pharma settings, aiming to reduce cost and complexity in therapeutic testing.
The Organoid Company
The Organoid Company provides accessible digital biology tools and ready-to-use organoid models to speed drug discovery. Our platform combines AI-assisted design for small molecules and proteins with seamless in silico to in vitro workflows. Key technologies include end-to-end automation, physiologically relevant organoid libraries, and integrated quality control. Researchers can run disease-model experiments from the library or request bespoke organoid development, with scalable production. The company targets B2B research and pharma settings, aiming to reduce cost and complexity in therapeutic testing.